Paper by Dr. Jay, Dr. Yang, Scott Hansen et al pub
Post# of 146884
not sure it is new, but I think it is.
It discusses the most positive result from the CD-10 trial of Leron vs. mild-to-moderate Covid: the NEWS2 results, which point toward the likelihood that Leron prevents patients with moderate Covid from progressing to critical.
https://www.sciencedirect.com/science/article...1824002601